Mpox | qPCR Assay
Mpox | qPCR Assay
Research Use Only
Mpox | qPCR Assay
–
Detecting Mpox Virus (Clade I and II)
Accurate PCR Detection of Mpox Virus (Clade I and II)
Precision Diagnostics for a Global Challenge
The Mpox qPCR Assay is a highly advanced diagnostic tool developed to address the challenges of detecting Mpox virus, a double-stranded DNA virus belonging to the Orthopoxvirus genus. Mpox has caused significant global outbreaks, with Clade II affecting 116 countries in 2022–2023, and Clade Ib declared a Public Health Emergency in 2024. The virus is transmitted through direct contact with lesions, contaminated objects, or sexual contact, posing a significant risk of rapid global spread.
This assay features dual gene targets and an integrated internal control, ensuring comprehensive and accurate detection of both Clade I and Clade II variants. Its advanced design accounts for viral mutations, providing greater reliability compared to single-target assays. With a streamlined workflow, compatibility with existing nucleic acid extraction systems, and reagents aliquoted for repeated use, the Mpox qPCR Assay offers laboratories an efficient and practical solution. Validated for reproducibility and stability, it delivers consistent results to support timely outbreak management and public health responses.
ASSAY TARGETS | |
G2R (Pan-Mpox) | F3L (Pan-Mpox) |
QUALITY CONTROL | |
Internal control included to monitor assay and sample quality through the entire workflow. | |
ORDERING INFORMATION | |
Mpox qPCR Assay | Cat Code: QP10691 |
Want to know more?
Contact us or visit our Vivalytic PCR Test Menu
Related Products
SARS-CoV-2 Dual Target, Flu A/B and RSV
Viral Respiratory Infection (VRI) Array
Vivalytic
Vivalytic Test Menu
COVID-19 | qPCR Assay
COVID-19 | qPCR Assay
–
Detecting SARS-CoV-2 (COVID-19)
Accurate PCR Detection of SARS-CoV-2
Randox Laboratories have recently developed a COVID-19 qPCR assay, which can be used for the detection of nucleic acid from SARS-CovV-2 (ORF1ab) and Severe Acute Respiratory Syndrome ((SARS)/SARS-like) viruses (E-gene). PCR based assays are recommended to include two tests. One to detect a universal SARS-like gene and a secondary confirmatory test for gene sequences exclusive to SARS-CoV-2.
In a multiplex format, the Randox qPCR assay allows for differentiation of SARS-CoV-2 and SARS-like corona infections from other seasonal respiratory illnesses caused by viruses to prevent rapid spread of infection through the isolation of positive cases.
Our assay is compatible with sample matrices including nasal / throat swabs. This test is intended for use in the clinical setting as an aid in the screening and isolation of individuals that require quarantine and immediate intervention.
Internal control provided to monitor assay/sample integrity through the extraction and PCR process.
Want to know more?
Contact us or visit our COVID-19 Monitoring & Management page
Related Products